Sutro Biopharma Announces First Patient Dosed in Phase 1 Trial of STRO-006, a Next-Generation ITGB6-Targeting ADC, in Advanced Solid Tumors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| (NASDAQ: STRO) | Delayed: 10.79 -0.75 (6.5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.54 | 52 Week High | $ | |||
| Open | $11.62 | 52 Week Low | $ | |||
| Day High | $11.80 | P/E | N/A | |||
| Day Low | $10.75 | EPS | $ | |||
| Volume | 439,854 | |||||
